We are monitoring the impact of COVID-19 on APAC Neurostimulation Devices Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11556
Share on
Share on

APAC Neurostimulation Devices Market Research Report – Segmented By Technology, Application, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11556
Pages: 90

APAC Neurostimulation Devices Market Size (2021 to 2026)

The Asia-Pacific neurostimulation devices market size is estimated to showcase a CAGR of 14.8% between 2021 to 2026.

Neuromodulation is a surgical technique in which a medical instrument is implanted to modulate and alter neuronal function. Neurostimulators work by providing electrical stimuli to the brain, peripheral nervous system, and spinal cord in patients with neurologic disorders. The growth for the APAC neurostimulation devices market is expected to be led by factors such as the rising prevalence of neurological disorders, increased understanding of neurological disorders among people in this region, and the occurrence of chronic diseases. On the other hand, the market growth can be increased due to the introduction of technologically innovative technologies and rising product demand.

The increasing geriatric population in developing countries like India and China is expected to drive regional demand growth. The APAC neurostimulation devices market is projected to rise due to the rising prevalence of neurological disorders and increased research into extending the applications of neuromodulation. Neurostimulators provide electrical stimulation to the brain, peripheral nervous system, and spinal cord of patients to aid in treating neurologic conditions. Several of the key drivers driving the neurostimulation devices industry are unmet patient needs in these disease communities. The government and private organizations' favorable government initiatives and increasing investments & funding further encourage APAC neurostimulation devices market growth.

However, stringent Asian government regulations and an increase in the total number of days required in the FDA approval process could suppress the region's growth. Restraining factors such as the high cost of neuromodulation procedures and supplies and the lack of a professional workforce limit the APAC neurostimulation devices market growth.

Impact of COVID-19 on APAC neurostimulation devices market:

The outbreak of COVID-19 has negatively impacted the market growth of APAC Neurostimulation market growth during the pandemic period. World health organizations announced the COVID-19 as an emergence to the healthcare systems. COVID-19 has spread across the Asian countries and led to the lockdown. Most Asian countries have stopped their projects as companies faced operational issues due to the disrupted supply chain; hence the market had a downfall. In the APAC region, the Indian market has witnessed a significant downfall in growth. However, the market is expected to register a healthy growth rate during the forecast period.

This research report on the APAC neurostimulation devices market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.

By Technology:

  • Internal
  • External

By Application:

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The APAC Neurostimulation Devices Market is projected to grow at a higher CAGR during the forecast period. The increasing geriatric population is to create market growth. Technological advances that enhance patient management are projected to drive growth in the market. As advanced technologies for restoring vision and assisting movement in paralysis becomes available, the use rate of these products on the market is projected to rise. China and India are the major contributors in the region.

In 2020, the China Neurostimulation Devices Market was expected to lead the APAC market during the forecast period. The prevalence of chronic diseases, the rise in demand for MRI scans, and increased understanding of neurological disorders contribute to market growth. Furthermore, economic development in emerging country China and rising healthcare expenditures are estimated to augment the market development.

During the forecast period, the Indian neurostimulation devices market has proven to be one of the most exciting in the APAC region. Consumer development is being fueled by ongoing research into the use of neurostimulators to treat interstitial cystitis and asthma. Furthermore, the country's high prevalence of neurological disorders, rising public and private investment, and favorable reimbursement schemes are expected to drive market growth.


Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc. are some of the noteworthy companies operating the APAC neurostimulation devices market.

    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
    1. By Technology
      1. Internal Neuromodulation
      2. External Neuromodulation
      3. Y-o-Y Growth Analysis, By Technology
      4. Market Attractiveness Analysis, By Technology
      5. Market Share Analysis, By Technology
    2. By Application
      1. Spinal Cord Stimulation
      2. Deep Brain Stimulation
      3. Sacral Nerve Stimulation
      4. Gastric Electrical Stimulation
      5. Transcutaneous Electrical Nerve Stimulation
      6. Transcranial Magnetic Stimulation
      7. Respiratory Electrical Stimulation
      8. Y-o-Y Growth Analysis, By Application
      9. Market Attractiveness Analysis, By Application
      10. Market Share Analysis, By Application
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
    1. Abbott
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Aleva neurotherapeutics SA
    3. Boston scientific corporation
    4. ElectroCore Inc.
    5. EndoStim Inc.
    6. Medtronic plc
    7. Nevro Corporation
    8. Neuronetics Inc.
    9. NeuroSigma, Inc.
    10. Synapse Biomedical Inc.
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of technology and application along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

APAC Neurostimulation Devices Market

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample